News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

December 5, 2023

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 5th December 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall have four members, in accordance with the applicable instructions resolved by the Annual General Meeting 2020. The three largest shareholders who are registered with Euroclear Sweden AB on…

November 30, 2023

Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)

STOCKHOLM, Sweden, 30th November 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces a change of Certified Adviser…

November 22, 2023

Lipidor AB (publ) publishes interim report for Q3 2023

STOCKHOLM, Sweden, 22nd November 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

October 27, 2023

Lipidor submits new patent application

STOCKHOLM, Sweden, 27th October 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that the company has filed…

October 18, 2023

Lipidor extends and expands cooperation with RELIFE

STOCKHOLM, Sweden, 18th October 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that a new agreement has…

September 20, 2023

Lipidor signs agreement for clinical phase III study

STOCKHOLM, Sweden, 20th September 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) has signed an agreement with Cliantha Research…

August 23, 2023

Correction: Lipidor AB (publ) publishes interim report for Q2 2023

STOCKHOLM, Sweden, 23 August 2023 – In Lipidor's interim report for the second quarter 2023, published today at 08:30, incorrect figures were…

August 23, 2023

Lipidor AB (publ) publishes interim report for Q2 2023

STOCKHOLM, Sweden, 23 August 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

June 29, 2023

Lipidor – Announcement of short-term funding

STOCKHOLM, Sweden, 29th June 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces that financing of SEK 2 million…

June 22, 2023

Lipidor – Swedish Medical Products Agency confirms clinical plan for new version of AKP02

STOCKHOLM, Sweden, 22nd June 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that the Swedish Medical Products…

June 8, 2023

Bulletin from the Annual General Meeting of Lipidor AB (publ)

The following resolutions were passed at the Annual General Meeting (the “AGM”) of Lipidor AB (publ) (the “Company”) on 8 June 2023…